Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with inteuleukin-2 treatment

Journal of Molecular Medicine

Volumn 76, Issue 3-4, 1998, Pages 215-221

  Henze, Günter ^a   Borgmann, Anja ^a   Von Stackelberg, Arend ^a   Baumgarten, Eckehard ^a   Uchanska Ziegler, Barbara ^a   Ziegler, Andreas ^a   Wittig, Burghardt ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; COMPLEMENTARY DNA; HLA ANTIGEN CLASS 1; INTERLEUKIN 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CLINICAL TRIAL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; INFANT; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; VACCINATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CANCER VACCINES; CHILD; CLINICAL PROTOCOLS; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; HLA-B ANTIGENS; HUMANS; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; PILOT PROJECTS; RECURRENCE; TRANSFECTION; VACCINATION;

EID: 0031885941     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050211     Document Type: Article

References (23)

1. Pui CH, Crist WM (1994) Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491-503
2. Henze G, Hartmann R, Fengler R (1994) Chemotherapy for relapsed childhood acute lymphoblastic leukemia: results of the BFM Study Group. Haematol Blood Transfus 36:374-379
3. Borgmann A, Schmid H, Hartmann R, Baumgarten E, Hermann K, Klingebiel T, Ebell W, Zintl F, Gadner H, Henze G for the BFM Relapse Study Group (1995) Autologous bone marrow transplants as compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. Lancet 95:873-876
4. Baumgarten E, Schmid H, Pohl U, Kühl J, Spaar HJ, Niemeyer C, Brzoska J, Siegert W, Henze G (1992) Phase I/II trial with low-dose interleukin-2 and interferon-gamma in children with high-risk leukaemia and non-Hodgkin's lymphoma after autologous hone marrow transplantation. Cytokines Hemopoiesis Oncol AIDS 2:757-782
5. Baumgarten E, Schmid H, Pohl U, Brzoska J, Linderkamp C, Siegert W, Henze G (1994) Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia 8:850-855
6. Chen W, You SG, Disis ML, Cheever MA (1993) Evaluation of the joining region segment of p210 ber-abl chimeric protein as potential leukemia-specific antigen to elicit class I MHC-restricted CTL responses. J Cell Biochem Suppl 17D:107
7. Fisch P, Weil-Hillman G, Uppenkamp M, Hank JA, Chen BP, Sosman JA, Bridges A, Colamonici OR, Sondel PM (1989) Antigen-specific recognition of autologons leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia. Blood 74:343-353
8. Hämmerling GJ, Hunt T, Dill O, Moreno J (1989) Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice. Eur J Immunol 19:599-604
9. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition renions of class I histocompatibility antigens. Nature 329:512-518
10. Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299
11. Plautz GE, Yang ZY, Wu BY, Gao X, Huang L and Nabel GJ (1993) Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 90:4645-4649
12. Hui K, Grosveld F, Festenstein H (1984) Rejektion of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Nature 311:750-752
13. Isobe K, Hasegawa Y, Iwamoto T, Hasegawa T, Kawashima K, Ding LN, Nakashima I (1989) Induction of antitumor immunity in mice by allo-major histocompatibility complex class I gene transfectant with strong antigen expression. J Natl Cancer Inst 81:1823-1827
14. Nabel GJ, Nabe EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307-11311
15. Borgmann A, Baumgarten E, Wittig B, Ziegler A, Uchanska-Ziegler B, Henze G (1995) Transfer of cDNA coding for an allogeneic HLA-class I antigen in lymphoblastic leukaemic cells. Med Pediatr Oncol 25:228
16. Naviaux-RK, Verma-IM (1992) Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol 3:540-547
17. Stratford-Perricaudel-LD, Levrero-M, Chasse-JF, Perricaudet-M, Briand-P (1990) Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1:241-256
18. Efstathiou S, Minson AC (1995) Herpes virus-based vectors. Br Med Bull 51:45-55
19. Chu G, Hayakawa H, Berg-P (1987) Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 15:1311-1326
20. Kalkbrenner F, Dippel E, Schroff M, Wittig B and Schultz G (1997) Nuclear application of antisense oligonucleotides by microinjection and ballistomagnetic transfer to identify G-protein heterotrimers activating phospholipase-C. Methods Mol Biol (in press)
21. Schadendorf D, Henz BM and Wittig B (1996) Interleukin 7 trials for melanoma treatment. Mol Med Today 2:144-145
22. Gansbacher B, Zier K, Cronin K, Hantzopuolos PA, Houghton A, Gilboa E, and Golde D (1992) Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-γ in irradiated human melanoma cells. Blood 80:2817-2825
23. Perez CF, Botchan MR, Tobias CA (1985) DNA mediated gene transfer efficiency is enhanced by ionizing and ultraviolet irradiation of rodent cells in vitro. I. Kinetics of enhancement. Radiat Res 104:200-213